Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ASCO Congress 2018: melanoma treatment.
Richtig E. Richtig E. Memo. 2018;11(4):261-265. doi: 10.1007/s12254-018-0455-4. Epub 2018 Nov 20. Memo. 2018. PMID: 30595751 Free PMC article. Review.
[Verwendung und Nutzen des Internets als Informationsquelle für Erkrankungen und Therapien in der Dermatologie: Usage and benefit of the Internet as a source of information on disease and therapy in dermatology].
Grossschaedl K, Vallant C, Dernoscheg MT, Richtig M, Öllinger A, Balakirski G, Wilsmann-Theis D, Nguyen VA, Weinlich G, Tsiogka A, Koelblinger P, Scheffel J, Richtig E, Richtig G. Grossschaedl K, et al. Among authors: richtig e. J Dtsch Dermatol Ges. 2023 Nov;21(11):1383-1386. doi: 10.1111/ddg.15199_g. Epub 2023 Oct 9. J Dtsch Dermatol Ges. 2023. PMID: 37811740 German. No abstract available.
Circulating Tumor DNA as a Marker for Treatment Response in Metastatic Melanoma Patients Using Next-Generation Sequencing-A Prospective Feasibility Study.
Berger M, Thueringer A, Franz D, Dandachi N, Talakić E, Richtig G, Richtig E, Rohrer PM, Koch L, Wolf IH, Koch C, Rainer BM, Koeller M, Pichler M, Gerritsmann H, Kashofer K, Aigelsreiter A. Berger M, et al. Among authors: richtig e, richtig g. Cancers (Basel). 2021 Jun 21;13(12):3101. doi: 10.3390/cancers13123101. Cancers (Basel). 2021. PMID: 34205831 Free PMC article.
Real-world outcomes using PD-1 antibodies and BRAF + MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland.
Schumann K, Mauch C, Klespe KC, Loquai C, Nikfarjam U, Schlaak M, Akçetin L, Kölblinger P, Hoellwerth M, Meissner M, Mengi G, Braun AD, Mengoni M, Dummer R, Mangana J, Sindrilaru MA, Radmann D, Hafner C, Freund J, Rappersberger K, Weihsengruber F, Meiss F, Reinhardt L, Meier F, Rainer B, Richtig E, Ressler JM, Höller C, Eigentler T, Amaral T, Peitsch WK, Hillen U, Harth W, Ziller F, Schatton K, Gambichler T, Susok L, Maul LV, Läubli H, Debus D, Weishaupt C, Börger S, Sievers K, Haferkamp S, Zenderowski V, Nguyen VA, Wanner M, Gutzmer R, Terheyden P, Kähler K, Emmert S, Thiem A, Sachse M, Gercken-Riedel S, Kaune KM, Thoms KM, Heinzerling L, Heppt MV, Tratzmiller S, Hoetzenecker W, Öllinger A, Steiner A, Peinhaupt T, Podda M, Schmid S, Wollina U, Biedermann T, Posch C. Schumann K, et al. Among authors: richtig e. J Eur Acad Dermatol Venereol. 2023 May;37(5):894-906. doi: 10.1111/jdv.18779. Epub 2022 Dec 12. J Eur Acad Dermatol Venereol. 2023. PMID: 36433688
Topical imiquimod in the treatment of metastatic melanoma to skin.
Wolf IH, Smolle J, Binder B, Cerroni L, Richtig E, Kerl H. Wolf IH, et al. Among authors: richtig e. Arch Dermatol. 2003 Mar;139(3):273-6. doi: 10.1001/archderm.139.3.273. Arch Dermatol. 2003. PMID: 12622616 No abstract available.
Prospective, randomized, multicenter, double-blind placebo-controlled trial comparing adjuvant interferon alfa and isotretinoin with interferon alfa alone in stage IIA and IIB melanoma: European Cooperative Adjuvant Melanoma Treatment Study Group.
Richtig E, Soyer HP, Posch M, Mossbacher U, Bauer P, Teban L, Svolba G, Wolf IH, Fritsch P, Zelger B, Volc-Platzer B, Gebhart W, Mischer P, Steiner A, Pachinger W, Hintner H, Gschnait F, Rappersberger K, Pilarski P, Pehamberger H; European Cooperative Adjuvant Melanoma Treatment Study Group. Richtig E, et al. J Clin Oncol. 2005 Dec 1;23(34):8655-63. doi: 10.1200/JCO.2004.00.8128. Epub 2005 Oct 31. J Clin Oncol. 2005. PMID: 16260701 Clinical Trial.
140 results